Laura and Issac Perlmutter Cancer Center at NYU Langone — New York, New York

Laura and Issac Perlmutter Cancer Center at NYU Langone is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

Laura and Issac Perlmutter Cancer Center at NYU Langone has participated in 6 clinical trials with 1 currently active.

Therapeutic areas: Squamous Cell Carcinoma (SCC), Recurrent or Metastatic, Platinum-refractory Cervical Cancer, Cervical Cancer.

Sponsors: Regeneron Pharmaceuticals, GOG Foundation, National Cancer Institute (NCI).

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Laura and Issac Perlmutter Cancer Center at NYU Langone?

Laura and Issac Perlmutter Cancer Center at NYU Langone has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Laura and Issac Perlmutter Cancer Center at NYU Langone conducted?

Laura and Issac Perlmutter Cancer Center at NYU Langone has 6 clinical trials on record, with 1 currently active. Their work covers Squamous Cell Carcinoma (SCC), Recurrent or Metastatic, Platinum-refractory Cervical Cancer, Cervical Cancer.

Is Laura and Issac Perlmutter Cancer Center at NYU Langone accredited by Crixeo Health?

Yes — Laura and Issac Perlmutter Cancer Center at NYU Langone holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Laura and Issac Perlmutter Cancer Center at NYU Langone?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.